1. Home
  2. TIC vs OCUL Comparison

TIC vs OCUL Comparison

Compare TIC & OCUL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

TIC

Acuren Corporation

HOLD

Current Price

$8.39

Market Cap

1.8B

Sector

N/A

ML Signal

HOLD

Logo Ocular Therapeutix Inc.

OCUL

Ocular Therapeutix Inc.

HOLD

Current Price

$8.26

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TIC
OCUL
Founded
1991
2006
Country
United States
United States
Employees
12760
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.8B
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
TIC
OCUL
Price
$8.39
$8.26
Analyst Decision
Buy
Strong Buy
Analyst Count
5
9
Target Price
$11.20
$23.56
AVG Volume (30 Days)
2.0M
2.5M
Earning Date
05-06-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$1,990,000.00
Revenue This Year
$44.09
$7.93
Revenue Next Year
$4.40
$96.07
P/E Ratio
N/A
N/A
Revenue Growth
N/A
3.48
52 Week Low
$6.36
$6.23
52 Week High
$14.94
$16.44

Technical Indicators

Market Signals
Indicator
TIC
OCUL
Relative Strength Index (RSI) 43.48 42.38
Support Level $6.55 $7.62
Resistance Level $10.66 $9.93
Average True Range (ATR) 0.48 0.46
MACD -0.06 -0.02
Stochastic Oscillator 33.07 24.47

Price Performance

Historical Comparison
TIC
OCUL

About TIC Acuren Corporation

TIC Solutions Inc is a provider of tech-enabled Testing, Inspection, Certification and Compliance (TICC), engineering, and geospatial services. It provides mission-critical services that are essential to the safety, reliability, and efficiency of industrial assets, buildings and public infrastructure. The company's services are often non-discretionary and are driven by regulatory requirements, customer risk management policies, and the need to extend the useful life of critical assets. It operates in North America and serve both public- and private-sector clients. Its public-sector clients include federal, state, and municipal agencies, public utilities, and environmental regulators. Its private-sector clients span industrial, infrastructure, construction, and real estate end markets.

About OCUL Ocular Therapeutix Inc.

Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.

Share on Social Networks: